CCR9 and inflammatory bowel disease: The expression of heteromeric complexes formed by D5R and CCR9 (the C-C chemokine receptor type 9) were up-regulated (assessed immunohistochemically via lymphoid cells) in the intestinal mucosa of IBD patients compared to healthy controls [27].